Xtant Medical Holdings XTNT
NYSE XTNT
$0.36 0.00 (-0.08%)
As of: Sep 30, 2026 · 3:56 PM EDT

Xtant Medical Holdings (XTNT) Research & Development (2013 - 2025)

Updated

Xtant Medical Holdings' Research & Development was $634,000 in Q3 2025, down 9.6% from $701,000 a year earlier but up 12.0% from the prior quarter.

Analysis

Xtant Medical Holdings (XTNT) Research & Development (2013 - 2025) Analysis & Trends

On a trailing twelve-month basis, Xtant Medical Holdings' Research & Development was $2.17 million through Sep 30, 2025, down 8.1% year-over-year; for FY2024, it came in at $2.39 million, up 78.5% from FY2023.

  • Research & Development has now increased for four consecutive years, with a five-year compound annual growth rate of 20.7% (FY2019 to FY2024).
  • In earlier years, Research & Development was $1.34 million in FY2023 (+46.0%), $915,000 in FY2022 (+5.2%), $870,000 in FY2021 (+32.4%) and $657,000 in FY2020 (-29.5%).
  • Quarterly Research & Development has moved between $128,000 (Q4 2020) and $701,000 (Q3 2024) over five years.
  • Compared with a year earlier, Research & Development has declined for three straight quarters, with growth averaging 72.6% over the last eight quarters.
  • The best year-over-year quarter for Research & Development over five years was Q2 2024 (growth of 253.3%); the worst was Q4 2020 (a decline of 50.2%).
  • Per Business Quant data, XTNT's Research & Development in the three quarters before Q3 2025 was $566,000 (Q2 2025), $443,000 (Q1 2025) and $522,000 (Q4 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Thermo Fisher Scientific 251.30 Bn 230.45 Bn 4.88 Bn 364.00 Mn
2 Abbott Laboratories 174.70 Bn 145.78 Bn 7.27 Bn 892.00 Mn
3 Danaher 158.94 Bn 142.76 Bn 3.61 Bn 412.00 Mn
4 Intuitive Surgical 145.87 Bn 125.42 Bn 1.96 Bn 370.60 Mn
5 Medtronic 111.49 Bn 77.36 Bn 6.34 Bn 771.00 Mn
6 Stryker 106.96 Bn 93.08 Bn 4.50 Bn 434.00 Mn
7 Boston Scientific 63.62 Bn 58.63 Bn 3.85 Bn 554.00 Mn
8 Edwards Lifesciences 50.80 Bn 34.92 Bn 1.35 Bn 278.90 Mn
9 Becton Dickinson 49.59 Bn 46.74 Bn 2.32 Bn 258.00 Mn
10 Xtant Medical Holdings 50.41 Mn 10.62 Mn 17.75 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 634,000.00
Jun 30, 2025 566,000.00
Mar 31, 2025 443,000.00
Dec 31, 2024 522,000.00
Sep 30, 2024 701,000.00
Jun 30, 2024 636,000.00
Mar 31, 2024 527,000.00
Dec 31, 2023 492,000.00
Sep 30, 2023 490,000.00
Jun 30, 2023 180,000.00
Mar 31, 2023 174,000.00
Dec 31, 2022 232,000.00
Sep 30, 2022 229,000.00
Jun 30, 2022 241,000.00
Mar 31, 2022 213,000.00
Dec 31, 2021 151,000.00
Sep 30, 2021 262,000.00
Jun 30, 2021 243,000.00
Mar 31, 2021 214,000.00
Dec 31, 2020 128,000.00
API Access

Xtant Medical Holdings Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=XTNT&period=max&api_key=YOUR_API_KEY